Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial-Reference-Cited by-同舟云学术

Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster-randomised, controlled trial

Published:2024-08 Issue:8 Volume:12 Page:e1300-e1311
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Aziz Asma Binte,Dudman Susanne,Julin Cathinka Halle,Ahmmed Faisal,Stene-Johansen Kathrine,Sandbu Synne,Øverbø Joakim,Dembinski Jennifer L,Wisløff Torbjørn,Rana Sohel,Basunia Ahsan-ul Habib,Haque Warda,Qadri Firdausi,Zaman Khalequ,Clemens John D

Funder

University of Oslo Faculty of Medicine

Publisher

Elsevier BV

Reference28 articles.

1. Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China;Qian;J Clin Virol,2023

2. Burden of hepatitis E virus infection in pregnancy and maternofoetal outcomes: a systematic review and meta-analysis;Bigna;BMC Pregnancy Childbirth,2020

3. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial;Zhu;Lancet,2010

4. Safety and effectiveness of a recombinant hepatitis E vaccine among women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled, trial;Zaman;Lancet Glob Health,2024

5. Hepatitis E vaccine—illuminating the barriers to use;Lynch;PLoS Negl Trop Dis,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global temporal trends and projections of acute hepatitis E incidence among women of childbearing age: Age-period-cohort analysis 2021;Journal of Infection;2024-10

2. Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial;The Lancet Global Health;2024-08